Severe multi-refractory Sneddon-Wilkinson disease, with fast response to oral roflumilast treatment

J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e467-e469. doi: 10.1111/jdv.19653. Epub 2023 Dec 7.
No abstract available

Publication types

  • Letter
  • Case Reports

MeSH terms

  • Administration, Oral
  • Aminopyridines* / administration & dosage
  • Aminopyridines* / therapeutic use
  • Benzamides* / administration & dosage
  • Benzamides* / therapeutic use
  • Cyclopropanes* / administration & dosage
  • Cyclopropanes* / therapeutic use
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phosphodiesterase 4 Inhibitors / administration & dosage
  • Phosphodiesterase 4 Inhibitors / therapeutic use

Substances

  • Cyclopropanes
  • Roflumilast
  • Aminopyridines
  • Benzamides
  • Phosphodiesterase 4 Inhibitors